Boston Scientific’s Ranger Drug-Coated Balloon Catheter

Ranger DCB is indicated for the treatment of patients with peripheral artery disease (PAD) in the superficial femoral artery (SFA) and proximal popliteal artery (PPA). Credit: Boston Scientific Corporation.



  • Ranger Drug-Coated Balloon Catheter
  • Ranger Drug-Coated Balloon Catheter
  • Ranger Drug-Coated Balloon Catheter